Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery
    Meeting Abstract

    Phung, M. T.; Berchuck, A.; Goode, E. L.; Goodman, M. T.; Hanley, G. E.; Richardson, J.; Grout, B.; Chase, A.; Deurloo, C. M.; Karlan, B. Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Variability in NTRK gene fusions does not appear to impact response to larotrectinib
    Meeting Abstract

    Ladanyi, M.; Roy-Chowdhuri, S.; Ritterhouse, L.; Sahm, F.; Norenberg, R.; Shen, K.; Chen, C.; Fellous, M.; Brega, N.; van Tilburg, C. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The Clinical Genome Resource (ClinGen) somatic cancer clinical domain working group
    Meeting Abstract

    Saliba, J.; Raca, G.; Roy, A.; King, I.; Selvarajah, S.; Xu, X.; Kanagal-Shamanna, R.; Satgunaseelan, L.; Meredith, D.; Evans, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in solid tumors with defects in polymerase epsilon
    Meeting Abstract

    Rousseau, B.; Bieche, I.; Pasmant, E.; Hamzaoui, N.; Leulliot, N.; Michon, L.; de Reynies, A.; Foote, M.; Masliah-Planchon, J.; Svrcek, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 biomarker analyses
    Meeting Abstract

    Lei, M.; Janjigian, Y. Y.; Ajani, J. A.; Moehler, M.; Wang, X.; Shen, L.; Garrido, M.; Gallardo, C.; Yamaguchi, K.; Wyrwicz, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of parsaclisib-ruxolitinib combination therapy in myelofibrosis patients (Pts) with low vs higher baseline platelet count (PC): A subgroup analysis of data from a phase 2 study
    Meeting Abstract

    Yacoub, A.; Borate, U.; Rampal, R.; Ali, H.; Wang, E.; Gerds, A.; Hobbs, G.; Kremyanskaya, M.; Winton, E.; O'Connell, C.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Tools for collecting pathologist annotations and understanding interobserver variability
    Meeting Abstract

    Elfer, K. N.; Blenman, K.; Dudgeon, S. N.; Garcia, V.; Ehinger, A.; Li, X. X.; Ly, A.; Peeters, D.; Werness, B.; Hanna, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations
    Meeting Abstract

    Yap, T. A.; Im, S. A.; Schram, A. M.; Sharp, A.; Balmana, J.; Baird, R. D.; Brown, J. S.; Schwaederle, M.; Pilling, E. A.; Moorthy, G.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Associations of inflammatory biomarkers with survival among patients with stage III colon cancer (CALGB/SWOG 80702 [Alliance])
    Meeting Abstract

    Cheng, E.; Qian, S.; Shields, A. F.; Cespedes Feliciano, E. M.; Nixon, A. B.; Shergill, A. P.; Guthrie, K. A.; Couture, F.; Kuebler, P.; Kumar, P.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacokinetic (PK) profile of a novel IKZF1/3 degrader, CFT7455, enables significant potency advantage over other IKZF1/3 degraders in models of multiple myeloma (MM) and the results of the initial treatment cohort from a first-in-human (FIH) phase 1/2 study of CFT7455 in MM
    Meeting Abstract

    Lonial, S.; Richard, S.; Matous, J. V.; Yee, A. J.; Shah, U.; Mehta-Shah, N.; Martin, T.; Muchtar, E.; Ailawadhi, S.; Richardson, P. G.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save